(EPAM) EPAM Systems - Ratings and Ratios
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US29414B1044
Engineering, Cloud, Analytics, Cybersecurity, Automation
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 38.4% |
| Value at Risk 5%th | 57.9% |
| Relative Tail Risk | -8.28% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.30 |
| Alpha | -31.96 |
| CAGR/Max DD | -0.26 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.554 |
| Beta | 1.234 |
| Beta Downside | 1.466 |
| Drawdowns 3y | |
|---|---|
| Max DD | 62.51% |
| Mean DD | 39.21% |
| Median DD | 39.12% |
Description: EPAM EPAM Systems November 04, 2025
EPAM Systems, Inc. (NYSE: EPAM) delivers end-to-end digital platform engineering and software development services, spanning requirement analysis, cloud road-mapping, AI-driven analytics, cybersecurity, and smart-automation operations for enterprise clients worldwide.
In FY 2023 the firm reported revenue of roughly $5.1 billion, up about 20 % year-over-year, and maintained an operating margin near 15 %, reflecting the scalability of its high-value consulting model. Growth is underpinned by macro-level IT spending trends-global enterprise software spend is projected to expand at a 6-7 % CAGR through 2028-and by strong demand in its core verticals such as financial services, healthcare, and high-tech, where digital transformation budgets remain resilient.
For a deeper quantitative assessment of EPAM’s valuation relative to peers, the ValueRay platform offers a granular, data-driven dashboard you may find useful.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (371.6m TTM) > 0 and > 6% of Revenue (6% = 317.9m TTM) |
| FCFTA 0.09 (>2.0%) and ΔFCFTA -3.40pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 31.88% (prev 52.32%; Δ -20.44pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.10 (>3.0%) and CFO 502.3m > Net Income 371.6m (YES >=105%, WARN >=100%) |
| Net Debt (-1.08b) to EBITDA (656.6m) ratio: -1.65 <= 3.0 (WARN <= 3.5) |
| Current Ratio 3.02 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (55.8m) change vs 12m ago -2.80% (target <= -2.0% for YES) |
| Gross Margin 28.30% (prev 30.84%; Δ -2.55pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 113.9% (prev 104.0%; Δ 9.90pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 74.38 (EBITDA TTM 656.6m / Interest Expense TTM 6.80m) >= 6 (WARN >= 3) |
Altman Z'' 6.88
| (A) 0.35 = (Total Current Assets 2.52b - Total Current Liabilities 835.3m) / Total Assets 4.84b |
| (B) 0.49 = Retained Earnings (Balance) 2.38b / Total Assets 4.84b |
| (C) 0.11 = EBIT TTM 505.9m / Avg Total Assets 4.65b |
| (D) 2.15 = Book Value of Equity 2.40b / Total Liabilities 1.12b |
| Total Rating: 6.88 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 68.04
| 1. Piotroski 7.0pt |
| 2. FCF Yield 5.10% |
| 3. FCF Margin 8.67% |
| 4. Debt/Equity 0.04 |
| 5. Debt/Ebitda -1.65 |
| 6. ROIC - WACC (= -0.22)% |
| 7. RoE 10.14% |
| 8. Rev. Trend 64.09% |
| 9. EPS Trend 19.03% |
What is the price of EPAM shares?
As of December 09, 2025, the stock is trading at USD 203.64 with a total of 898,055 shares traded.
Over the past week, the price has changed by +6.94%, over one month by +11.64%, over three months by +23.83% and over the past year by -17.62%.
Over the past week, the price has changed by +6.94%, over one month by +11.64%, over three months by +23.83% and over the past year by -17.62%.
Is EPAM a buy, sell or hold?
EPAM Systems has received a consensus analysts rating of 3.95.
Therefore, it is recommended to buy EPAM.
- Strong Buy: 7
- Buy: 7
- Hold: 6
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the EPAM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 207.9 | 2.1% |
| Analysts Target Price | 207.9 | 2.1% |
| ValueRay Target Price | 194.7 | -4.4% |
EPAM Fundamental Data Overview November 25, 2025
Market Cap USD = 10.08b (10.08b USD * 1.0 USD.USD)
P/E Trailing = 27.6305
P/E Forward = 15.5763
P/S = 1.9027
P/B = 2.6831
P/EG = 1.1889
Beta = 1.767
Revenue TTM = 5.30b USD
EBIT TTM = 505.9m USD
EBITDA TTM = 656.6m USD
Long Term Debt = 25.0m USD (from longTermDebt, last quarter)
Short Term Debt = 40.5m USD (from shortTermDebt, last quarter)
Debt = 155.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.08b USD (from netDebt column, last quarter)
Enterprise Value = 9.00b USD (10.08b + Debt 155.2m - CCE 1.24b)
Interest Coverage Ratio = 74.38 (Ebit TTM 505.9m / Interest Expense TTM 6.80m)
FCF Yield = 5.10% (FCF TTM 459.1m / Enterprise Value 9.00b)
FCF Margin = 8.67% (FCF TTM 459.1m / Revenue TTM 5.30b)
Net Margin = 7.01% (Net Income TTM 371.6m / Revenue TTM 5.30b)
Gross Margin = 28.30% ((Revenue TTM 5.30b - Cost of Revenue TTM 3.80b) / Revenue TTM)
Gross Margin QoQ = 27.24% (prev 28.77%)
Tobins Q-Ratio = 1.86 (Enterprise Value 9.00b / Total Assets 4.84b)
Interest Expense / Debt = 1.49% (Interest Expense 2.31m / Debt 155.2m)
Taxrate = 25.62% (36.8m / 143.6m)
NOPAT = 376.3m (EBIT 505.9m * (1 - 25.62%))
Current Ratio = 3.02 (Total Current Assets 2.52b / Total Current Liabilities 835.3m)
Debt / Equity = 0.04 (Debt 155.2m / totalStockholderEquity, last quarter 3.73b)
Debt / EBITDA = -1.65 (Net Debt -1.08b / EBITDA 656.6m)
Debt / FCF = -2.36 (Net Debt -1.08b / FCF TTM 459.1m)
Total Stockholder Equity = 3.67b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.67% (Net Income 371.6m / Total Assets 4.84b)
RoE = 10.14% (Net Income TTM 371.6m / Total Stockholder Equity 3.67b)
RoCE = 13.71% (EBIT 505.9m / Capital Employed (Equity 3.67b + L.T.Debt 25.0m))
RoIC = 10.19% (NOPAT 376.3m / Invested Capital 3.69b)
WACC = 10.42% (E(10.08b)/V(10.24b) * Re(10.56%) + D(155.2m)/V(10.24b) * Rd(1.49%) * (1-Tc(0.26)))
Discount Rate = 10.56% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.66%
[DCF Debug] Terminal Value 70.14% ; FCFE base≈505.0m ; Y1≈519.0m ; Y5≈581.4m
Fair Price DCF = 123.8 (DCF Value 6.84b / Shares Outstanding 55.2m; 5y FCF grow 2.72% → 3.0% )
EPS Correlation: 19.03 | EPS CAGR: 2.97% | SUE: 0.49 | # QB: 0
Revenue Correlation: 64.09 | Revenue CAGR: 6.34% | SUE: 1.72 | # QB: 5
EPS next Quarter (2026-03-31): EPS=2.77 | Chg30d=+0.055 | Revisions Net=+7 | Analysts=13
EPS next Year (2026-12-31): EPS=12.47 | Chg30d=+0.337 | Revisions Net=+12 | Growth EPS=+9.0% | Growth Revenue=+7.0%
P/E Trailing = 27.6305
P/E Forward = 15.5763
P/S = 1.9027
P/B = 2.6831
P/EG = 1.1889
Beta = 1.767
Revenue TTM = 5.30b USD
EBIT TTM = 505.9m USD
EBITDA TTM = 656.6m USD
Long Term Debt = 25.0m USD (from longTermDebt, last quarter)
Short Term Debt = 40.5m USD (from shortTermDebt, last quarter)
Debt = 155.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.08b USD (from netDebt column, last quarter)
Enterprise Value = 9.00b USD (10.08b + Debt 155.2m - CCE 1.24b)
Interest Coverage Ratio = 74.38 (Ebit TTM 505.9m / Interest Expense TTM 6.80m)
FCF Yield = 5.10% (FCF TTM 459.1m / Enterprise Value 9.00b)
FCF Margin = 8.67% (FCF TTM 459.1m / Revenue TTM 5.30b)
Net Margin = 7.01% (Net Income TTM 371.6m / Revenue TTM 5.30b)
Gross Margin = 28.30% ((Revenue TTM 5.30b - Cost of Revenue TTM 3.80b) / Revenue TTM)
Gross Margin QoQ = 27.24% (prev 28.77%)
Tobins Q-Ratio = 1.86 (Enterprise Value 9.00b / Total Assets 4.84b)
Interest Expense / Debt = 1.49% (Interest Expense 2.31m / Debt 155.2m)
Taxrate = 25.62% (36.8m / 143.6m)
NOPAT = 376.3m (EBIT 505.9m * (1 - 25.62%))
Current Ratio = 3.02 (Total Current Assets 2.52b / Total Current Liabilities 835.3m)
Debt / Equity = 0.04 (Debt 155.2m / totalStockholderEquity, last quarter 3.73b)
Debt / EBITDA = -1.65 (Net Debt -1.08b / EBITDA 656.6m)
Debt / FCF = -2.36 (Net Debt -1.08b / FCF TTM 459.1m)
Total Stockholder Equity = 3.67b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.67% (Net Income 371.6m / Total Assets 4.84b)
RoE = 10.14% (Net Income TTM 371.6m / Total Stockholder Equity 3.67b)
RoCE = 13.71% (EBIT 505.9m / Capital Employed (Equity 3.67b + L.T.Debt 25.0m))
RoIC = 10.19% (NOPAT 376.3m / Invested Capital 3.69b)
WACC = 10.42% (E(10.08b)/V(10.24b) * Re(10.56%) + D(155.2m)/V(10.24b) * Rd(1.49%) * (1-Tc(0.26)))
Discount Rate = 10.56% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.66%
[DCF Debug] Terminal Value 70.14% ; FCFE base≈505.0m ; Y1≈519.0m ; Y5≈581.4m
Fair Price DCF = 123.8 (DCF Value 6.84b / Shares Outstanding 55.2m; 5y FCF grow 2.72% → 3.0% )
EPS Correlation: 19.03 | EPS CAGR: 2.97% | SUE: 0.49 | # QB: 0
Revenue Correlation: 64.09 | Revenue CAGR: 6.34% | SUE: 1.72 | # QB: 5
EPS next Quarter (2026-03-31): EPS=2.77 | Chg30d=+0.055 | Revisions Net=+7 | Analysts=13
EPS next Year (2026-12-31): EPS=12.47 | Chg30d=+0.337 | Revisions Net=+12 | Growth EPS=+9.0% | Growth Revenue=+7.0%
Additional Sources for EPAM Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle